Related by context. Frequent words. (Click for all words.) 72 AVE# 72 CR# vcMMAE 71 anticancer compound 71 HGS ETR1 71 Sym# 71 RGB # 71 CYC# 71 Pivotal Phase III 70 Phase 2a trial 70 KNS # 70 HCV protease inhibitor 70 Carfilzomib 70 ALN TTR# 70 OXi# 70 LY# [003] 70 Azedra 70 BAY #-# 69 angiogenesis inhibitor 69 humanized monoclonal antibody 69 deforolimus 69 TELCYTA 69 Amrubicin 69 pseudobulbar affect PBA 68 pertuzumab 68 axitinib 68 IMGN# 68 humanized anti 68 TG# [001] 68 HuMax CD# 68 phase IIb 68 Aurora kinase 68 Phase Ib 68 PXD# 68 talactoferrin 68 phase IIa 67 HER2 positive metastatic breast 67 IMC A# 67 AP# [003] 67 LymphoStat B 67 Azixa 67 hematological cancers 67 Phenoptin 67 relapsed multiple myeloma 67 orally bioavailable 67 PEGylated 67 DAVANAT 67 relapsed refractory multiple myeloma 67 registrational trial 67 Allovectin 7 R 67 Cethromycin 66 CA4P 66 Nexavar ® 66 drug conjugate 66 Phase 2a clinical 66 thymalfasin 66 tanespimycin 66 Phase 1b 66 Phase 2b trial 66 MNTX 66 GRN#L 66 nab paclitaxel 66 glufosfamide 66 Virulizin R 66 ALN VSP 66 Phase 1b clinical 66 methylnaltrexone 66 Atiprimod 66 Phase IIa trial 66 Bortezomib 66 eltrombopag 66 cutaneous T cell 66 ELND# 66 squalamine 66 Phase III Clinical Trial 66 SinuNase 66 Cethrin 66 dose limiting toxicities 66 seliciclib 66 Clinical Trial Results 66 Ofatumumab 66 Diamyd ® 66 Alemtuzumab 66 diabetic neuropathic pain 65 MAP# 65 imetelstat 65 teduglutide 65 decitabine 65 Pivotal Phase 65 ZD# [001] 65 Pivotal Trial 65 Phase IIa clinical trials 65 BCX# 65 Voreloxin 65 MLN# 65 Irinotecan 65 Phase 1b trial 65 LY# [002] 65 NGX# 65 ISIS # 65 INCB# [002] 65 administered subcutaneously